Friday, February 07, 2020 9:41:17 AM
"We also saw significant gross margin improvement in comparison to the first quarter of fiscal 2020, as the issues that were negatively impacting our gross margin were largely mitigated in the second quarter. This includes, in part, the mitigation of the increase in tariffs, the resolution of the Black DiamondTM ("BD6") annealing yields, and increases in capacity for our BD6 processes. These improvements, coupled with continued management of operating expenses, resulted in EBITDA of 21% of revenue in the second quarter of fiscal 2020, which demonstrates the improved leverage in our business when compared to 11% in the prior year period."
"Unit volumes sold were up 35% as compared to the first quarter of fiscal 2020, and 23% as compared to the second quarter of the prior fiscal year. Growth in precision molded optics ("PMO") products continues to be driven by 5G demand. Although our average selling price for the PMO product group is lower in comparison to prior periods, this is really driven by the volume increase in lower price point products. In fact, we did not experience price erosion for any product group in the second quarter, with the change in average selling prices solely reflecting revenue product mix, which shifts from quarter to quarter."
New York Yankees and Duke Basketball
Recent LPTH News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:51:34 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 04:23:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:10:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:10:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 11:55:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:27:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:12:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:07:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:02:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:56:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:48:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:46:20 AM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 12/20/2023 01:02:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:01:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:53:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:11:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:01:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:15:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:14:46 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/14/2023 09:08:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 08:01:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM